Wells Fargo’s TriSalus Life Sciences TLSI Stock Holding History

Wells Fargo’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	44,728 +33,221	+289%	+$132K	﹤0.01%	5198
2026 Q1	$46K	Sell	11,507 -23,407	-67%	-$115K	﹤0.01%	5478
2025 Q4	$244K	Buy	34,914 +20,261	+138%	+$113K	﹤0.01%	4953
2025 Q3	$68.1K	Buy	14,653 +3,878	+36%	+$18.2K	﹤0.01%	5463
2025 Q2	$58.7K	Buy	10,775 +9,774	+976%	+$52.4K	﹤0.01%	5456
2025 Q1	$5.53K	Buy	1,001 +1,000	+100,000%	+$5.32K	﹤0.01%	6006
2024 Q4	$5	Hold	1	–	–	﹤0.01%	6910
2024 Q3	$5	Sell	1 -1,225	-100%	-$6.49K	﹤0.01%	6760
2024 Q2	$6.77K	Sell	1,226 -93	-7%	-$789	﹤0.01%	5820
2024 Q1	$12.9K	Buy	1,319 +2	+0.2%	+$18	﹤0.01%	5696
2023 Q4	$11.1K	Buy	1,317 +1,316	+131,600%	+$6.77K	﹤0.01%	5807
2023 Q3	$5	Buy	+1	New	+$8	﹤0.01%	7484

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Wells Fargo's TLSI Position: Q2 2026 in Review

Wells Fargo increased its TriSalus Life Sciences (TLSI) stake by 289% in Q2 2026, buying an estimated $132K and bringing the position to 44,728 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #5198.

Wells Fargo first reported a position in TLSI in Q3 2023 and has held it in 12 quarters since. The position peaked at $244K in Q4 2025. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

Wells Fargo held 44,728 shares of TriSalus Life Sciences worth $204K as of Q2 2026.
Wells Fargo bought 33,221 TriSalus Life Sciences shares in Q2 2026, an estimated $132K.
TriSalus Life Sciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5198 holding.
Wells Fargo first reported a position in TriSalus Life Sciences in Q3 2023 and has held it in 12 quarters since.
Wells Fargo's TriSalus Life Sciences position peaked at $244K in Q4 2025.
79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.